Showing 2 posts of 2 posts found.

AZ sign

AstraZeneca and Isis Pharma in $65m drugs collaboration

August 3, 2015
Manufacturing and Production, Research and Development AstraZeneca, Isis Pharma, Isis Pharmaceuticals, antisense, drug R&D

Isis Pharmaceuticals and AstraZeneca have announced a strategic collaboration to discover and develop antisense therapies for cardiovascular, metabolic and renal …

biogen idec image

Biogen signs neurology deal

September 11, 2013
Research and Development, Sales and Marketing Biogen IDEC, Isis, antisense, neurology

Biogen Idec and Isis Pharmaceuticals have entered their fourth partnership in two years in a deal that will see the …

Latest content